Kotra Industries Berhad (KLSE: KOTRA)
Health Care · Pharmaceuticals · MY
RM3.73
-0.53% today · -11.6% 1Y
Kotra Industries Berhad (KLSE: KOTRA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $136.98M.
Over the last twelve months the share price has lost 11.6%, trading between 3.70 and 4.49.
Tweenvest scores Kotra Industries Berhad across four factors: quality 89/100, value 62/100, growth 31/100, dividend 76/100. Its strongest factor is quality.
KOTRA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $136.98M
- Revenue (TTM)
- $55.42M
- P/E
- 14.51
- EPS
- 0.26
- Dividend yield
- 6.84%
- Beta (5Y)
- -0.09
- 52-week high
- RM4.49
- 52-week low
- RM3.70
- Avg volume (3M)
- —
- Shares outstanding
- 148.31M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,257.35 | +0.16% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.37 | +0.42% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.48 | -0.76% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.15 | +0.29% |
Figures last refreshed Aug 18, 2026.